Cargando…

Interleukin-11: A Potential Biomarker and Molecular Therapeutic Target in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancer and is a fast progressive disease when left untreated. Identification of potential biomarkers in NSCLC is an ongoing area of research that aims to detect, diagnose, and prognosticate patients early to optimize treatment. We review th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leung, Jason Hongting, Ng, Benjamin, Lim, Wei-Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318853/ https://www.ncbi.nlm.nih.gov/pubmed/35883698 http://dx.doi.org/10.3390/cells11142257

Ejemplares similares

IL11 (Interleukin-11) Causes Emphysematous Lung Disease in a Mouse Model of Marfan Syndrome
por: Ng, Benjamin, et al.
Publicado: (2023)

Interleukin-22: a potential therapeutic target in atherosclerosis
por: Luo, Jin-Wen, et al.
Publicado: (2021)

Immunomodulation of Interleukin-34 and its Potential Significance as a Disease Biomarker and Therapeutic Target
por: Ge, Yun, et al.
Publicado: (2019)

The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion
por: Andreasson, Anders S.I., et al.
Publicado: (2017)

Wnt-11 as a Potential Prognostic Biomarker and Therapeutic Target in Colorectal Cancer
por: Gorroño-Etxebarria, Irantzu, et al.
Publicado: (2019)

KIF11 is a potential prognostic biomarker and therapeutic target for adrenocortical carcinoma
por: Zhou, Yan, et al.
Publicado: (2023)

Matrix Metalloproteinase 11 Is a Potential Therapeutic Target in Lung Adenocarcinoma
por: Yang, Haoran, et al.
Publicado: (2019)

BCL11A: a potential diagnostic biomarker and therapeutic target in human diseases
por: Yin, Jiawei, et al.
Publicado: (2019)

miR-145 as a Potential Biomarker and Therapeutic Target in Patients with Non-Small Cell Lung Cancer
por: Cho, William C., et al.
Publicado: (2023)

Critical roles of the lncRNA CASC11 in tumor progression and cancer metastasis: The biomarker and therapeutic target potential
por: Wang, Bei, et al.
Publicado: (2020)

Role of TRPM7 in Cancer: Potential as Molecular Biomarker and Therapeutic Target
por: Yee, Nelson S.
Publicado: (2017)

The PITX gene family as potential biomarkers and therapeutic targets in lung adenocarcinoma
por: Zhang, Chunyi, et al.
Publicado: (2021)

Interleukin-17: A potential therapeutic target in COVID-19
por: Mendoza, Vicky M. Montaño
Publicado: (2020)

Interleukin-17 as a potential therapeutic target for chronic pain
por: Jiang, Xiaojuan, et al.
Publicado: (2022)

Screening for Potential Therapeutic Agents for Non-Small Cell Lung Cancer by Targeting Ferroptosis
por: Zhao, Xin, et al.
Publicado: (2022)

Biomarkers/Molecular Targets, Immunotherapy, and Treatments for Non–Small Cell Lung Cancer
por: Waxman, Elizabeth S., et al.
Publicado: (2016)

Transgenic interleukin 11 expression causes cross-tissue fibro-inflammation and an inflammatory bowel phenotype in mice
por: Lim, Wei-Wen, et al.
Publicado: (2020)

ACSL4 as a Potential Target and Biomarker for Anticancer: From Molecular Mechanisms to Clinical Therapeutics
por: Hou, Jun, et al.
Publicado: (2022)

CKAP4 is a potential exosomal biomarker and therapeutic target for lung cancer
por: Nagoya, Akihiro, et al.
Publicado: (2023)

Interleukin-6 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension
por: Furuya, Yoshiaki, et al.
Publicado: (2010)

Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?
por: Tanase, Daniela Maria, et al.
Publicado: (2019)

REPLY TO: Interleukin-17: a potential therapeutic target in COVID-19
por: Piaserico, Stefano, et al.
Publicado: (2020)

RANBP9 as potential therapeutic target in non-small cell lung cancer
por: Tessari, Anna, et al.
Publicado: (2020)

Targeting Microglia in Alzheimer’s Disease: From Molecular Mechanisms to Potential Therapeutic Targets for Small Molecules
por: Althafar, Ziyad M.
Publicado: (2022)

Transgelin in bladder cancer: A potential biomarker and therapeutic target
por: Li, Wei-Ming, et al.
Publicado: (2019)

Interleukin-11 signaling underlies fibrosis, parenchymal dysfunction, and chronic inflammation of the airway
por: Ng, Benjamin, et al.
Publicado: (2020)

Long non-coding RNAs in non-small cell lung cancer as biomarkers and therapeutic targets
por: Chen, Jing, et al.
Publicado: (2014)

Identification and validation of novel prognostic biomarkers and therapeutic targets for non-small cell lung cancer
por: Lai, Li-Ting, et al.
Publicado: (2023)

CircRNAs in colorectal cancer: potential biomarkers and therapeutic targets
por: Zhang, Yuying, et al.
Publicado: (2023)

Small molecule metabolites: discovery of biomarkers and therapeutic targets
por: Qiu, Shi, et al.
Publicado: (2023)

The role of interleukin-22 in lung health and its therapeutic potential for COVID-19
por: Fang, Si, et al.
Publicado: (2022)

Molecular Expression Profile Reveals Potential Biomarkers and Therapeutic Targets in Canine Endometrial Lesions
por: Voorwald, Fabiana Azevedo, et al.
Publicado: (2015)

Identification of lncRNAs associated with T cells as potential biomarkers and therapeutic targets in lung adenocarcinoma
por: SUN, LU, et al.
Publicado: (2023)

Biology and therapeutic potential of interleukin-10
por: Saraiva, Margarida, et al.
Publicado: (2019)

Small Non-coding RNAs: New Class of Biomarkers and Potential Therapeutic Targets in Neurodegenerative Disease
por: Watson, Callum N., et al.
Publicado: (2019)

Interleukin-20 is involved in dry eye disease and is a potential therapeutic target
por: Wang, Hsiao-Hsuan, et al.
Publicado: (2022)

NFAT as a Biomarker and Therapeutic Target in Non–Small Cell Lung Cancer–Related Brain Metastasis
por: Peng, Lu, et al.
Publicado: (2021)

m(6)A regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

Identification of super-enhancer-driven peptidyl arginine deiminases as potential biomarkers and therapeutic targets for osimertinib-resistant non-small cell lung cancer
por: Li, Hang, et al.
Publicado: (2022)

Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer
por: Casneuf, Tineke, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r3eht7683nldvdf3obn3oteaad